ABSTRACT
BACKGROUND: The association between HIV and cardiovascular disease (CVD) has been reported in several studies. However, there is paucity of information on the prevalence of subclinical disease as well as its associated risk factors in sub-Saharan African population. The aim of this study was to determine the prevalence and associated risk factors of peripheral artery disease (PAD) among virologically suppressed HIV-infected participants in Kwara State, Nigeria. METHODS: This study was conducted between July 2018 and December 2018. A total of 150 HIV-infected participants aged between 20 and 55 years and 50 HIV non-infected age-matched controls were randomly recruited in the study. Sociodemographic, anthropometric and clinical data were collected using a well-structured questionnaire. Ankle brachial index (ABI) was measured, PAD was defined as ABI of < 0.9. Cryopreserved serum was used to evaluate lipid profile parameters. Student's t-test and Chi-square were used to compare continuous and categorical variables. Associations of CVD risk factors and clinical data, and lipid profile with low ABI were assessed using logistic regression analysis. RESULTS: The study participants had a mean age of 43.73 ± 8.74, majority were females (72.7%) with a mean duration on ART of 7.73 ± 3.52 years. Hypertension was present in 15.9%, diabetes 4%, family history of CVD 8.6% and metabolic syndrome 17.3% in the study group. The study participants recorded significantly lower mean values for ABI, HDL-C and significantly higher mean values of TG (P < 0.05) compared to the control group. The prevalence of low ABI (14.6%) was higher in the study group compared to the control group (2%). A significantly negative correlation between ABI and duration on ART (r = - 0.163, P = 0.041) and a positive correlation between viral load and TG were observed in the study group. TC (OR 1.784, P = 0.011), LDL-C (OR 1.824, P = 0.010) and CD4 cell count < 200 cells/mm3 (OR 2.635, P = 0.364) were associated with low ABI in the participants. CONCLUSION: Viral suppression with combined antiretroviral therapy and long term treatment is associated with dyslipidaemia, with increased risk of PAD. Prevalence of PAD in virologically-suppressed individuals does not differ from the controls in the population studied.
Subject(s)
Anti-Retroviral Agents/therapeutic use , HIV Infections/complications , HIV , Peripheral Arterial Disease/epidemiology , Adult , Aged , Ankle Brachial Index , CD4 Lymphocyte Count , Cross-Sectional Studies , Diabetes Mellitus/epidemiology , Diabetes Mellitus/virology , Dyslipidemias/epidemiology , Dyslipidemias/virology , Female , HIV Infections/drug therapy , HIV Infections/virology , Humans , Hypertension/epidemiology , Hypertension/virology , Lipids/blood , Male , Middle Aged , Nigeria , Peripheral Arterial Disease/virology , Prevalence , Risk Factors , Young AdultABSTRACT
The objective of the present study was to explore on the possible protective effects of the saponins and alkaloid-rich fractions of Colocasia esculenta L. Schott leaves on high-fat diet-induced changes in rats. High-fat diet (HFD)-fed rats were treated orally with 10mg/kg b.wt of saponin-rich fraction [SPF], 10mg/kg bw of alkaloid-rich fraction [ALF] and 400mg/kg bw of Crude aqueous extract of C. esculenta [CEAE] for 28 days. The effects of the treatments on body weight, wet white adipose (WAT) tissue, liver marker enzymes and liver histomorphology were studied. High-fat diet induced body weight gain and increased the serum levels of liver enzymes, cholesterol and triglycerides in rats. Increased body weight changes were observed in HFD-control while the alkaloid and CEAE treatments significantly decreased the weight gain of treated rats. Oral treatment with CEAE and fractions significantly decreased all the biochemical parameters (p<0.05) except cholesterol levels. Microscopical examination of the WAT showed decreased adipocyte sizes upon treatments with CEAE and fractions while the liver histoarchitecture showed a better preservation upon treatments with SPF and CEAE. The outcomes from the present study suggest that C. esculenta leaves significantly reduced fat accumulation in adipose tissues and ameliorated HFD-induced liver damage. The alkaloids and saponins present in the plant product may be the phytoconstituents responsible for the weight attenuating and hepatoprotection activities respectively.